Methyl 1-(2,4-Difluoro-phenyl)-5-((4-tert-butyl-thiosemicarbazono)methyl)-1H-pyrazole-4-carboxylate
CAS : 264233-05-8
Ref. 3D-FM102381
| 100mg | Arrêté |
Informations sur le produit
Nom :
Methyl 1-(2,4-Difluoro-phenyl)-5-((4-tert-butyl-thiosemicarbazono)methyl)-1H-pyrazole-4-carboxylate
Description :
Methyl 1-(2,4-difluoro-phenyl)-5-((4-tert-butyl-thiosemicarbazono)methyl)-1H-pyrazole-4-carboxylate (SNX-111) is a drug that has been shown to be useful in the treatment of inflammatory bowel disease. It has a low potency, but it is activated by colonic bacteria and has been shown to have clinical use for the treatment of bowel disease. SNX-111 also acts as a potent antagonist of actin filaments and y-27632. It has been shown to reduce cardiac hypertrophy and primary sclerosing cholangitis. SNX-111 inhibits VSMC proliferation in vitro and in vivo.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
395.43 g/mol
Formule :
C17H19F2N5O2S
Degré de pureté :
Min. 95%
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
